Main content 1 Menu 2 Search 3 Footer 4
+A
A
-A
High contrast
HOME JOURNAL CRITERIA NETWORK HELP ABOUT

Current criteria:

Regional:

WPRlM journal selection criteria(2023)

Minimum standards for the suspension and removal of WPRIM approved journals

Countries journal selection criteria:

Philippines

Submit your journal information>

Contact NJSCs>

Brain Tumor Research and Treatment

2002 (v1, n1) to Present ISSN: 1671-8925

Articles

About

Year of publication

Save Email

Sort by

Best match
Relevance
PubYear
JournalTitle

DISPLAY OPTIONS

Format:

Per page:

Save citations to file

Selection:

Format:

Create file Cancel

Email citations

To:

Please check your email address first!

Selection:

Format:

Send email Cancel

386

results

page

of 39

1

Cite

Cite

Copy

Share

Share

Copy

Primary Malignant Lymphoma of the Cranial Vault with Extra- and Intracranial Extension.

Myeong Jin KO ; Sung Nam HWANG ; Yong Sook PARK ; Teak Kyun NAM

Brain Tumor Research and Treatment.2013;1(1):32-35. doi:10.14791/btrt.2013.1.1.32

Bone involvement is a common finding in many types of lymphomas, particularly in advanced stages. However, cranial vault affliction has been regarded as an exceedingly rare presentation. Here, we report the case of a patient with cranial vault lymphoma who presented with a scalp mass. An 81-year-old woman presented with a gradually growing and non-painful frontal scalp mass that she noticed one month before admission. It was a flatly elevated, round mass measuring about 6x4x4 cm. Computed tomography and magnetic resonance imaging of the brain revealed a contrast-enhancing intracranial extradural mass at the counter-location of the scalp mass. The superior sagittal sinus was involved at the tumor site. Cerebral angiography showed that the tumor feeding vessels originated from the bilateral external carotid arteries. An operation was performed and the tumors were removed together with the involved bone. The pathologic diagnosis was malignant diffuse large B-cell type lymphoma. The patient was transferred to the Hemato-Oncology department for chemotherapy. Primary lymphoma of the cranial vault with scalp mass is very rare but it should be considered in the differential diagnosis of scalp masses. Although the results of reported cases are variable, the combination of surgery, radiation, and chemotherapy appears to offer favorable outcomes.
Aged, 80 and over ; B-Lymphocytes ; Brain ; Carotid Artery, External ; Cerebral Angiography ; Diagnosis ; Diagnosis, Differential ; Drug Therapy ; Female ; Humans ; Lymphoma* ; Magnetic Resonance Imaging ; Scalp ; Superior Sagittal Sinus

Aged, 80 and over ; B-Lymphocytes ; Brain ; Carotid Artery, External ; Cerebral Angiography ; Diagnosis ; Diagnosis, Differential ; Drug Therapy ; Female ; Humans ; Lymphoma* ; Magnetic Resonance Imaging ; Scalp ; Superior Sagittal Sinus

2

Cite

Cite

Copy

Share

Share

Copy

Inflamed Symptomatic Sellar Arachnoid Cyst: Case Report.

Kwang Hyon PARK ; Ho Shin GWAK ; Eun Kyung HONG ; Sang Hyun LEE

Brain Tumor Research and Treatment.2013;1(1):28-31. doi:10.14791/btrt.2013.1.1.28

Sellar arachnoid cysts are rare; an infected arachnoid cyst is extremely rare as only one case has been reported to date in the literature. Here, we report a patient with an infected or inflamed sellar arachnoid cyst that was successfully treated with transsphenoidal surgery (TSA). A 53-year-old female with a history of chronic sinusitis developed a headache 5 months ago, and one month before admission polyuria, polydipsia, and abnormal vaginal bleeding occurred. The magnetic resonance imaging (MRI) showed a sellar cystic mass with a thickened pituitary stalk. Preoperative hormonal study revealed normal pituitary hormone levels except for a moderate elevation of prolactin. She was diagnosed with diabetes insipidus of the central nervous system origin based on a water-deprivation test. TSA was performed under an impression of symptomatic Rathke's cleft cyst according to the MRI findings. Intraoperative findings showed confirmation of turbid intracystic contents, but micro-organisms were unidentified on microbial culture. Pathology of the cyst wall revealed inflamed meningoepithelial lining cells compatible with an arachnoid cyst.
Arachnoid Cysts ; Arachnoid* ; Central Nervous System ; Diabetes Insipidus ; Female ; Headache ; Humans ; Inflammation ; Magnetic Resonance Imaging ; Middle Aged ; Pathology ; Pituitary Gland ; Polydipsia ; Polyuria ; Prolactin ; Sinusitis ; Uterine Hemorrhage

Arachnoid Cysts ; Arachnoid* ; Central Nervous System ; Diabetes Insipidus ; Female ; Headache ; Humans ; Inflammation ; Magnetic Resonance Imaging ; Middle Aged ; Pathology ; Pituitary Gland ; Polydipsia ; Polyuria ; Prolactin ; Sinusitis ; Uterine Hemorrhage

3

Cite

Cite

Copy

Share

Share

Copy

Pain Assessment in Brain Tumor Patients after Elective Craniotomy.

Young Deok KIM ; Jae Hyun PARK ; Seung Ho YANG ; Il Sup KIM ; Jae Taek HONG ; Jae Hoon SUNG ; Byung Chul SON ; Sang Won LEE

Brain Tumor Research and Treatment.2013;1(1):24-27. doi:10.14791/btrt.2013.1.1.24

OBJECTIVE: This study was performed to assess the postoperative pain of brain tumor patients who underwent elective craniotomy and to evaluate the factors associated with pain intensity. METHODS: From January 2010 to December 2011, 47 patients with newly diagnosed brain tumors who underwent craniotomy were enrolled. The postoperative pain status was assessed daily until discharge using the visual analogue scale (VAS). RESULTS: The study participants comprised of 22 males and 25 females with ages ranging from 18-76 years (median age, 50 years). Patients were divided into two groups: the painful group included patients who had a VAS score of more than 3 during their hospital stay after the craniotomy, and the tolerable group included patients who had a VAS score of 1 to 3 during their hospital stay. There were no differences between the two groups in terms of age, sex, location of surgery, history of diabetes, hypertension and smoking, body mass index, and hospital stay. Univariate analysis revealed that operating time, length of wound, head fixation, and perioperative administration of opioid were not associated with the intensity of postoperative pain. Daily assessment of VAS revealed the two peaks of pain on the operation day and the 4th postoperative day. The intensity of pain during the ambulation period was higher than that during intensive care unit (ICU) stay. CONCLUSION: Pain following elective craniotomy for brain tumor removal is insufficiently managed, especially after discharge from the ICU. More attention needs to be paid to patients' pain throughout the hospital stay.
Analgesia ; Body Mass Index ; Brain Neoplasms* ; Brain* ; Craniotomy* ; Female ; Head ; Humans ; Hypertension ; Intensive Care Units ; Length of Stay ; Male ; Pain Management ; Pain Measurement* ; Pain, Postoperative ; Smoke ; Smoking ; Walking ; Wounds and Injuries

Analgesia ; Body Mass Index ; Brain Neoplasms* ; Brain* ; Craniotomy* ; Female ; Head ; Humans ; Hypertension ; Intensive Care Units ; Length of Stay ; Male ; Pain Management ; Pain Measurement* ; Pain, Postoperative ; Smoke ; Smoking ; Walking ; Wounds and Injuries

4

Cite

Cite

Copy

Share

Share

Copy

An Updated Nationwide Epidemiology of Primary Brain Tumors in Republic of Korea.

Kyu Won JUNG ; Johyun HA ; Seung Hoon LEE ; Young Joo WON ; Heon YOO

Brain Tumor Research and Treatment.2013;1(1):16-23. doi:10.14791/btrt.2013.1.1.16

OBJECTIVE: The aim of this report is to provide accurate nationwide epidemiologic data on primary brain and central nervous system (CNS) tumors in Republic of Korea. In 2010, we had reported first nationwide epidemiologic data on primary brain tumors diagnosed in 2005. In this report, we updated the data by analyzing primary brain and CNS tumors diagnosed in 2010 using the data from national cancer incidence database. METHODS: Data on primary brain and CNS tumors diagnosed in 2010 were collected from the Korean Central Cancer Registry. Crude and age-standardized rates were calculated in terms of gender, age, and histological type. RESULTS: A total of 10,004 patients diagnosed with primary brain and CNS tumors in 2010 were included in this study. Brain and CNS tumors occurred in females more often than in males (female to male, 1.59 : 1). The most common tumor was meningioma (35.5%). Pituitary tumors (18.7%), gliomas (15.1%), and nerve sheath tumors (10.3%) were followed in incidence. Glioblastoma accounted for 34.6% of all gliomas. In children (<20 years), sellar region tumors (pituitary and craniopharyngioma), embryonal/primitive/medulloblastoma, and germ cell tumors were the most common tumors. CONCLUSION: Data from this study should provide valuable information regarding the primary brain tumors epidemiology in Republic of Korea.
Brain ; Brain Neoplasms* ; Central Nervous System ; Child ; Epidemiology* ; Female ; Glioblastoma ; Glioma ; Humans ; Incidence ; Korea ; Male ; Meningioma ; Neoplasms, Germ Cell and Embryonal ; Nerve Sheath Neoplasms ; Pituitary Neoplasms ; Republic of Korea*

Brain ; Brain Neoplasms* ; Central Nervous System ; Child ; Epidemiology* ; Female ; Glioblastoma ; Glioma ; Humans ; Incidence ; Korea ; Male ; Meningioma ; Neoplasms, Germ Cell and Embryonal ; Nerve Sheath Neoplasms ; Pituitary Neoplasms ; Republic of Korea*

5

Cite

Cite

Copy

Share

Share

Copy

Molecular Culprits Generating Brain Tumor Stem Cells.

Se Yeong OH ; Hyunggee KIM

Brain Tumor Research and Treatment.2013;1(1):9-15. doi:10.14791/btrt.2013.1.1.9

Despite current advances in multimodality therapies, such as surgery, radiotherapy, and chemotherapy, the outcome for patients with high-grade glioma remains fatal. Understanding how glioma cells resist various therapies may provide opportunities for developing new therapies. Accumulating evidence suggests that the main obstacle for successfully treating high-grade glioma is the existence of brain tumor stem cells (BTSCs), which share a number of cellular properties with adult stem cells, such as self-renewal and multipotent differentiation capabilities. Owing to their resistance to standard therapy coupled with their infiltrative nature, BTSCs are a primary cause of tumor recurrence post-therapy. Therefore, BTSCs are thought to be the main glioma cells representing a novel therapeutic target and should be eliminated to obtain successful treatment outcomes.
Adult Stem Cells ; Brain Neoplasms* ; Brain* ; Drug Therapy ; Glioma ; Humans ; Radiotherapy ; Recurrence ; Stem Cells*

Adult Stem Cells ; Brain Neoplasms* ; Brain* ; Drug Therapy ; Glioma ; Humans ; Radiotherapy ; Recurrence ; Stem Cells*

6

Cite

Cite

Copy

Share

Share

Copy

Current Trends in Glioblastoma Multiforme Treatment: Radiation Therapy and Immune Checkpoint Inhibitors.

Sarah NICHOLAS ; Dimitris MATHIOS ; Jacob RUZEVICK ; Christopher JACKSON ; Isaac YANG ; Michael LIM

Brain Tumor Research and Treatment.2013;1(1):2-8. doi:10.14791/btrt.2013.1.1.2

Glioblastoma multiforme (GBM) is the most common primary brain cancer. Even with aggressive combination therapy, the median life expectancy for patients with GBM remains approximately 14 months. In order to improve the outcomes of patients with GBM, the development of newer treatments is critical. The concept of using the immune system as a therapeutic option has been suggested for several decades; by harnessing the body's adaptive immune mechanisms, immunotherapy could provide a durable and targeted treatment against cancer. However, many cancers, including GBM, have developed mechanisms that protect tumor cells from being recognized and eliminated by the immune system. For new immunotherapeutic regimens to be successful, overcoming immunosuppression via immune checkpoint signaling should be taken into consideration.
Brain Neoplasms ; Glioblastoma* ; Humans ; Immune System ; Immunosuppression ; Immunotherapy ; Life Expectancy ; Radiosurgery

Brain Neoplasms ; Glioblastoma* ; Humans ; Immune System ; Immunosuppression ; Immunotherapy ; Life Expectancy ; Radiosurgery

7

Cite

Cite

Copy

Share

Share

Copy

New Take-Off to an International Journal.

Heon YOO

Brain Tumor Research and Treatment.2013;1(1):1-1. doi:10.14791/btrt.2013.1.1.1

No abstract available.

8

Cite

Cite

Copy

Share

Share

Copy

Oculomotor Nerve Schwannoma: A Case Report.

Yong Hwan CHO ; Kyung Su SUNG ; Young Jin SONG ; Dae Cheol KIM ; Sunseob CHOI ; Ki Uk KIM

Brain Tumor Research and Treatment.2014;2(1):43-47. doi:10.14791/btrt.2014.2.1.43

Schwannomas account for about 8% of intracranial tumors and 90% are vestibular schwannomas. Oculomotor schwannoma without neurofibromatosis is extremely rare. A 41-year-old female presented with complaints of blurred vision, and the neurologic examination revealed afferent pupillary defect and decreased visual acuity of the left side. Brain magnetic resonance image showed an extra axial mass in the left superior orbital fissure. The patient underwent major surgery via the fronto-temporal approach. The tumor originated from the oculomotor nerve and was subtotally removed under microscopic surgery. The pathological findings confirmed the tumor as a schwannoma. After surgery, ptosis and medial gaze limitation of the left eye was detected, but the symptoms improved gradually.
Adult ; Brain ; Female ; Humans ; Neurilemmoma* ; Neurofibromatosis 1 ; Neurologic Examination ; Neuroma, Acoustic ; Oculomotor Nerve* ; Orbit ; Pupil Disorders ; Visual Acuity

Adult ; Brain ; Female ; Humans ; Neurilemmoma* ; Neurofibromatosis 1 ; Neurologic Examination ; Neuroma, Acoustic ; Oculomotor Nerve* ; Orbit ; Pupil Disorders ; Visual Acuity

9

Cite

Cite

Copy

Share

Share

Copy

Extradural Dermoid Cyst Located in the Lateral Sphenoid Ridge.

Seok Jin KO ; Kyung Jae PARK ; Dong Hyuk PARK ; Shin Hyuk KANG

Brain Tumor Research and Treatment.2014;2(1):39-42. doi:10.14791/btrt.2014.2.1.39

Dermoid cysts are rare congenital tumors that occur primarily at the midline at a characteristic intradural location. However, dermoid cysts located at extradural and lateral regions have been rarely reported until now. In the present study, the authors demonstrate the unusual instance of an intracranial extradural dermoid cyst at the lateral sphenoid ridge. A 53-year-old woman admitted because of progressive headache and dizziness. The patient had no neurologic deficits, and magnetic resonance imaging with no contrast enhancement revealed a mass at the right sphenoid ridge. The mass was accompanied with sphenoid bone erosion visible on computed tomography. The patient underwent right pterional craniotomy, and the tumor including the capsule was totally resected. Presence of a dermoid cyst was confirmed with histopathological examination. The patient had no complications during the postoperative period. This study suggests that dermoid cyst should be considered for differential diagnosis of extradural and lateral intracranial masses.
Craniotomy ; Dermoid Cyst* ; Diagnosis, Differential ; Dizziness ; Female ; Headache ; Humans ; Magnetic Resonance Imaging ; Middle Aged ; Neurologic Manifestations ; Postoperative Period ; Sphenoid Bone

Craniotomy ; Dermoid Cyst* ; Diagnosis, Differential ; Dizziness ; Female ; Headache ; Humans ; Magnetic Resonance Imaging ; Middle Aged ; Neurologic Manifestations ; Postoperative Period ; Sphenoid Bone

10

Cite

Cite

Copy

Share

Share

Copy

Glioblastoma in a Patient with Neurofibromatosis Type 1: A Case Report and Review of the Literature.

Tae Seok JEONG ; Gi Taek YEE

Brain Tumor Research and Treatment.2014;2(1):36-38. doi:10.14791/btrt.2014.2.1.36

Neurofibromatosis type 1 (NF1) is an autosomal dominantly inherited familial tumor syndrome. Benign tumors such as pilocytic astrocytoma, optic glioma make up the majority of intracranial neoplasms in patients with NF1. There have only been a handful of cases in which adult glioblastoma presented with NF1. A 32-year-old male presented with headache and radiological studies showing a high grade intra-axial tumor. The patient underwent gross total surgical excision and the pathology revealed glioblastoma. After the surgery, he received concomitant chemo-radiotherapy with temozolomide and adjuvant temozolomide chemotherapy. We report a NF1 patient who developed glioblastoma and reviewed related articles.
Adult ; Astrocytoma ; Brain Neoplasms ; Drug Therapy ; Glioblastoma* ; Hand ; Headache ; Humans ; Male ; Neurofibromatosis 1* ; Optic Nerve Glioma ; Pathology

Adult ; Astrocytoma ; Brain Neoplasms ; Drug Therapy ; Glioblastoma* ; Hand ; Headache ; Humans ; Male ; Neurofibromatosis 1* ; Optic Nerve Glioma ; Pathology

Country

Republic of Korea

Publisher

The Korean Brain Tumor Society; The Korean Society for Neuro-Oncology

ElectronicLinks

http://synapse.koreamed.org/LinkX.php?code=0212BTRT

Editor-in-chief

Heon Yoo

E-mail

journal@btrt.org

Abbreviation

Brain Tumor Res Treat

Vernacular Journal Title

ISSN

2288-2405

EISSN

2288-2413

Year Approved

2014

Current Indexing Status

Currently Indexed

Start Year

2013

Description

Brain Tumor Research and Treatment (Official Abbreviation: Brain Tumor Res Treat, BTRT) is the official journal of the Korean Brain Tumor Society, the Korean Society for Neuro-Oncology, and the Korean Society for Pediatric Neuro-Oncology. The aim of BTRT is to publish the highest quality papers which are dedicated to the advancement of care of patients with central nervous system tumors. BTRT welcomes submissions related to the collaborative investigations in basic, translational, and clinical research covering the whole field of neuro-oncology throughout the world. This journal publishes editorials, original articles, reviews, case reports, technical notes, and letters to the editor.

Related Sites

WHO WPRO GIM

Help Accessibility
DCMS Web Policy
CJSS Privacy Policy

Powered by IMICAMS( 备案号: 11010502037788, 京ICP备10218182号-8)

Successfully copied to clipboard.